Recent Advances in
Primary
Immunodysregulation
Disorders
Abstract Submission
Clinicians and researchers caring for and/or investigating patients with primary immunodysregulatory disorders are invited to submit abstracts on their findings to present at the RAPID 2026 conference.
To ensure timely review and notification of travel grant recipients, priority consideration will be given to high-quality abstracts submitted early.
Closing date for Abstracts: August 14th, 2026
Abstract Guidelines
- Abstracts must be written in English and use the attached template.
- Submit abstract using the webform. If you have any questions, please email RAPID@sidra.org.
- After being assessed by reviewers, successful abstracts will be accepted for either oral or poster presentation.
- Notification regarding abstract acceptance will be sent to the submitting author via e-mail.
- Presenters of accepted abstracts must register for the conference.
- Applicants living outside Qatar will automatically be considered for travel awards, including return flight and accommodation.